109 results on '"Chemotherapy -- Technology application"'
Search Results
2. Haystack Oncology, Lisata Therapeutics initiate research collaboration
3. Hebei University of Technology Researchers Broaden Understanding of Nanoplatforms (Fe [ [3] ] O [ [4] ] @TiO [ [2] ] Microspheres: Harnessing O [ [2] ] Release and ROS Generation for Combination CDT/PDT/PTT/Chemotherapy in Tumours)
4. Rice University breakthrough could make automated dosing systems universal
5. UMich researchers use chip that can assess if lung cancer treatment is working
6. Investigators at Shandong University Detail Findings in Nanoparticles (Dual-targeted Nanoformulation With Janus Structure for Synergistic Enhancement of Sonodynamic Therapy and Chemotherapy)
7. New Gold Nanoparticles Study Findings Have Been Reported from Donghua University (Diselenide-crosslinked Nanogels Laden With Gold Nanoparticles and Methotrexate for Immunomodulation-enhanced Chemotherapy and Computed Tomography Imaging of Tumors)
8. New Nanohydrogels Data Have Been Reported by Researchers at Bengbu Medical College (Ph/thermal Dual-sensitive Nanoparticle-hydrogel Composite Based On Pluronic and Carboxymethyl Chitosan for In Situ Injection and Enhanced Chemo-photothermal ...)
9. Reports from Guangdong Pharmaceutical University Add New Data to Findings in Non-Small Cell Lung Cancer (Genetically Engineered Pd-1 Displaying Nanovesicles for Synergistic Checkpoint Blockades and Chemo-metabolic Therapy Against Non-small Cell ...)
10. Researchers from Sichuan University Provide Details of New Studies and Findings in the Area of Breast Cancer (A Quad-functional On-demand Released Nanomissile Achieves Cascade Amplification Therapy of Triple-negative Breast Cancer Through ...)
11. New Data from Southwest Petroleum University Illuminate Findings in Nanocatalysts (H2o2 Self-supplying and Gsh-depleting Nanocatalyst for Copper Metabolism-based Synergistic Chemodynamic Therapy and Chemotherapy)
12. PRodrug technology for Immunotherapy-priming via patient-friendly at-home MEtronomic dosing
13. New Cancer Findings from King Fahad Medical City Described (Nanoplatform for the Delivery of Topotecan in the Cancer Milieu: An Appraisal of its Therapeutic Efficacy)
14. Study Findings on Cancer Published by Researchers at Yantai University (Complex polymeric nanomicelles co-delivering doxorubicin and dimethoxycurcumin for cancer chemotherapy)
15. Findings on Rabies Virus Detailed by Investigators at Chinese Academy of Sciences (A Biodegradable Nanocapsule for Through-skull Nir-ii Fluorescence Imaging/magnetic Resonance Imaging and Selectively Enhanced Radio-chemotherapy for Orthotopic ...)
16. Researchers from Fuzhou University Discuss Findings in Military Weapons (Endogenous Stimuli-responsive Autonomous Separation of Dual-targeting Dna Guided Missile From Nanospacecraft for Intelligent Targeted Cancer Therapy)
17. Investigators from Ulsan National Institute of Science and Technology (UNIST) Target Cancer (Cancer-selective Supramolecular Chemotherapy By Disassembly-assembly Approach)
18. New Gold Nanorods Findings from Fuzhou University Discussed (Nanosized Janus Aunr-pt Motor for Enhancing Nir-ii Photoacoustic Imaging of Chemotherapy)
19. Findings from Fuzhou University Provides New Data on Gold Nanorods (Nanosized Janus Aunr-pt Motor for Enhancing Nir-ii Photoacoustic Imaging of Deep Tumor and Pt2+ Ion-based Chemotherapy)
20. New Cancer Study Results Reported from Shaanxi University of Chinese Medicine (Mild Hyperthermia Synergized Chemotherapy By Bi2se3/mose2 Nanosaucers for Cancer Treatment With Negligible Thermal Resistance)
21. New Findings from King Abdulaziz University Describe Advances in Colon Cancer (In Vitro Optimization, Characterization and Anti-tumor Evaluation Against Colorectal Cancer of a Novel 5-fluorouracil Oral Nanosuspension Using Soy Protein, ...)
22. Studies from Binzhou Medical University Describe New Findings in Nanoparticles (Developing Smart Nanoparticles Responsive to the Tumor Micro-Environment for Enhanced Synergism of Thermo-Chemotherapy With PA/MR Bimodal Imaging)
23. Northeast Forestry University Reports Findings in Imidazole Therapy (P Polyoxometalate Modified By Zeolite Imidazole Framework for the Ph-responsive Electrodynamic/chemodynamic Therapy)
24. New Nanoclusters Findings from Vellore Institute of Technology Described [Hydrazone Conjugated and Dox Loaded Pegylated-fe3o4 Mesoporous Magnetic Nanoclusters (Mncs): Hyperthermia and In Vitro Chemotherapy]
25. EMA validates Bristol Myers' MAA for Opdivo in combo with Yervoy and and Opdivo + chemotherapy to treat unresectable advanced, recurrent or metastatic ESCC
26. Researchers at South China University of Technology Have Reported New Data on Drug Delivery Systems (Dual Drug Delivery System With Flexible and Controllable Drug Ratios for Synergistic Chemotherapy)
27. Researchers at Liaocheng University Target Cancer (A Microrna-21-responsive Doxorubicin-releasing Sticky-flare for Synergistic Anticancer With Silencing of Microrna and Chemotherapy)
28. Astellas, Seagen and Merck Announce FDA Acceptance of Supplemental Biologics License Applications for PADCEV(r) (enfortumab vedotin-ejfv) with KEYTRUDA(r) (pembrolizumab) for the First-Line Treatment of Certain Patients With Locally Advanced or Metastatic Urothelial Cancer
29. Astellas, Seagen and Merck Announce FDA Acceptance of sBLA for PADCEV(r) (enfortumab vedotin-ejfv) with KEYTRUDA(r) (pembrolizumab) for the First-Line Treatment of Certain Patients With Locally Advanced or Metastatic Urothelial Cancer
30. Immigration denies cancer patient's son's immigration application
31. Chinese scientists propose new treatment strategy for nasopharyngeal carcinoma
32. Research Conducted at Mohammed V University Has Updated Our Knowledge about Cancer (Risk reduction in a cancer chemotherapy production unit: Contribution of an automated drug dispensing system)
33. HTG Molecular says HTG EdgeSeq technology highlighted in posters
34. Studies from Second Hospital of Jilin University Provide New Data on Doxorubicin Therapy (Doxorubicin-loaded nanoscale metal-organic framework for tumor-targeting combined chemotherapy and chemodynamic therapy)
35. New Supramolecular Research Findings from Institute of Nano Science and Technology Discussed (Plasmonically Active Supramolecular Polymer-metal-organic Framework Hydrogel Nanocomposite for Localized Chemo-photothermal Therapy)
36. Astellas, Seagen and Merck Announce FDA Acceptance of Supplemental Biologics License Applications for PADCEV® enfortumab vedotin-ejfv with KEYTRUDA® pembrolizumab for the First-Line Treatment of Certain Patients With Locally Advanced or Metasta
37. Purchase Of Fully Automated Chemotherapeutic Drug Preparation Equipment
38. IIT-D identifies new drug delivery platform technology
39. Investigators at Second Hospital of Jilin University Release New Data on Doxorubicin Therapy (Doxorubicin-loaded nanoscale metal-organic framework for tumor-targeting combined chemotherapy and chemodynamic therapy)
40. National Taipei University of Technology Details Findings in Cancer (Theranostic Iron@gold Core-shell Nanoparticles for Simultaneous Hyperthermia-chemotherapy Upon Photo-stimulation)
41. Investigators at Sun Yat-Sen University Have Reported New Data on Choriocarcinoma (The role of a semi-automated NanoVelcro system in capturing circulating tumor cells and evaluating their prognostic value for gestational choriocarcinoma)
42. Studies from East China University of Science and Technology Further Understanding of Organosilica (Biodegradable organosilica magnetic micelles for magnetically targeted MRI and GSH-triggered tumor chemotherapy)
43. Recent Findings from Institute of Environmental Biotechnology Has Provided New Information about Antimicrobials (The Chemo Enzymatic Functionalization of Chitosan Zeolite Particles Provides Antioxidant and Antimicrobial Properties)
44. U.S. Food and Drug Administration Accepts Bristol Myers Squibb's Applications for Opdivo (nivolumab) + Yervoy (ipilimumab) and Opdivo + Chemotherapy for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
45. United States : U.S. Food and Drug Administration Accepts Bristol Myers Squibbs Applications for Opdivo (nivolumab) + Yervoy (ipilimumab) and Opdivo + Chemotherapy for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
46. U.S. Food and Drug Administration Accepts Bristol Myers Squibb's Applications for Opdivo (nivolumab) + Yervoy (ipilimumab) and Opdivo + Chemotherapy for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
47. United States : EMA Validates Bristol Myers Squibbs Applications for Opdivo (nivolumab) + Yervoy (ipilimumab) and Opdivo + Chemotherapy as First-Line Treatments for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
48. EMA Validates Bristol Myers Squibbs Applications for Opdivo (nivolumab) + Yervoy (ipilimumab) and Opdivo + Chemotherapy as First-Line Treatments for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
49. EMA Validates Bristol Myers Squibb's Applications for Opdivo (nivolumab) + Yervoy (ipilimumab) and Opdivo + Chemotherapy as First-Line Treatments for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
50. Khemosafe Builds Smart Device to Mitigate Against Hazardous Chemotherapy Exposure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.